-
Mashup Score: 28
Scientists at the FDA propose making Covid vaccinations a regular, once-a-year shot that is updated to match current strains of the SARS-CoV-2 virus.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
FDA proposes annual Covid shot matched to current strains The discussion on this at FDA’s public panel on Thursday could be VERY interesting. And @HelenBranswell and I will liveblog. https://t.co/1YxgN6hKjO
-
-
Mashup Score: 36
Scientists at the FDA propose making Covid vaccinations a regular, once-a-year shot that is updated to match current strains of the SARS-CoV-2 virus.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
Where are we headed with #Covid shots? On Friday @US_FDA will ask expert advisers their thoughts about its plan to move to yearly shots updated to try to keep up with the ever changing SARS-2 virus. @matthewherper explains. #VRBPAC https://t.co/50Kn4iBmkb
-
-
Mashup Score: 0
C diff patients live in fear of a recurrence, says gastroenterologist Paul Feuerstadt, MD. RBX2660 has entered the FDA pipeline and looks to end this vicious cycle.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#ICYMI: We interviewed @DrPaulGastro to find out what's next for the recurrent C difficile therapy, #RBX2660, now that the @US_FDA's #VRBPAC voted to recommend a Biologics License Application (#BLA). https://t.co/SGiljjCz9X https://t.co/0MObFlTNub
-
-
Mashup Score: 0
An FDA advisory committee will meet on September 22, 2022 to decide whether to approve a biologics license application (BLA) for Ferring’s recurrent C difficile biotherapeutic, RBX2660.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
Potential approval of a biotherapeutic for recurrent C difficile infection (#CDI): On September 22, the FDA's #VRBPAC advisory committee will decide whether to grant a Biologics License Application (#BLA) to @ferring's RBX2660. https://t.co/LsjbvAUz2T
-
-
Mashup Score: 0
An FDA advisory committee will meet on September 22, 2022 to decide whether to approve a biologics license application (BLA) for Ferring’s recurrent C difficile biotherapeutic, RBX2660.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#Breaking: On September 22, the FDA’s Vaccines and Related Biological Products Advisory Committee (#VRBPAC) will meet to decide whether to approve a biologics license application (#BLA) for @ferring’s recurrent C difficile biotherapeutic, #RBX2660. #CDI https://t.co/XBTwoZvb6i
-
-
Mashup Score: 82
We’re live-blogging today’s FDA advisory panel meeting on whether and how Covid-19 vaccines should be updated.
Source: STATCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @HelenBranswell: #VRBPAC votes 19 to 2 to recommend updating Covid vaccines to include an Omicron strain. https://t.co/T17WN4tWTN
-
-
Mashup Score: 77
We’re live-blogging today’s FDA advisory panel meeting on whether and how Covid-19 vaccines should be updated.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
Final entry here. https://t.co/HoOGXUYCre
-
RT @HelenBranswell: #VRBPAC votes 19 to 2 to recommend updating Covid vaccines to include an Omicron strain. https://t.co/T17WN4tWTN
-
Tracking an FDA advisory panel meeting on updating Covid vaccines. Great context and play-by-play @HelenBranswell @matthewherper https://t.co/fqsZIDpoDf
-
-
Mashup Score: 2
After an all-day meeting, the FDA’s Vaccine and Related Biological Products Advisory Committee (VRBPAC) voted 90% YES to recommend this fall’s COVID-19 booster doses target Omicron.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#BREAKING: 90% (19/21) of the FDA’s vaccine advisory committee (#VRBPAC) voted to recommend updated COVID-19 #boosters that specifically target #Omicron and its subvariants. https://t.co/aPJzOh4VOy
-
-
Mashup Score: 69
We’re live-blogging today’s FDA advisory panel meeting on whether and how Covid-19 vaccines should be updated.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
#VRBPAC votes 19 to 2 to recommend updating Covid vaccines to include an Omicron strain. https://t.co/T17WN4tWTN
-
Panel votes 19-2-0 that U.S. should have Omicron-containing boosters. https://t.co/HoOGXUYCre
-
A lot has been happening. More here: https://t.co/HoOGXUYCre
-
-
Mashup Score: 26
We’re live-blogging today’s FDA advisory panel meeting on whether and how Covid-19 vaccines should be updated.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
#VRBPAC is speeding through presentations from the various Covid vaccine manufacturers on the work they've done to test updated vaccines. Some surprises. @matthewherper will add a post in our live blog after the companies complete their presentations. https://t.co/T17WN4tWTN
-
Some interesting data from the CDC. TLDR: Vaccines work, but their efficacy does wane and newer Omicron shots might help. https://t.co/HoOGXUYCre https://t.co/479LX9MQ2w
-
Repeating to fix error: Where are we headed with #Covid shots? On Thursday @US_FDA will ask expert advisers their thoughts about its plan to move to yearly shots updated to try to keep up with the ever changing virus. @matthewherper explains. #VRBPAC https://t.co/50Kn4iAOuD